How delayed and non-adherent treatment contribute to onward transmission of malaria: a modelling study
Introduction Artemether-lumefantrine (AL) is the most widely-recommended treatment for uncomplicated Plasmodium falciparum malaria. Its efficacy has been extensively assessed in clinical trials. In routine healthcare settings, however, its effectiveness can be diminished by delayed access to treatme...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2019-12-01
|
| シリーズ: | BMJ Global Health |
| オンライン･アクセス: | https://gh.bmj.com/content/4/6/e001856.full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|